391 related articles for article (PubMed ID: 26033283)
1. Impact of Ocular Chronic Graft-versus-Host Disease on Quality of Life.
Sun YC; Chai X; Inamoto Y; Pidala J; Martin PJ; Flowers ME; Shen TT; Lee SJ; Jagasia M
Biol Blood Marrow Transplant; 2015 Sep; 21(9):1687-91. PubMed ID: 26033283
[TBL] [Abstract][Full Text] [Related]
2. Vision-Related Quality of Life in Patients with Ocular Graft-versus-Host Disease.
Saboo US; Amparo F; Abud TB; Schaumberg DA; Dana R
Ophthalmology; 2015 Aug; 122(8):1669-74. PubMed ID: 26001816
[TBL] [Abstract][Full Text] [Related]
3. Impact of ocular graft-versus-host disease on visual quality of life in patients after allogeneic stem cell transplantation: questionnaire study.
Riemens A; Te Boome LC; Kalinina Ayuso V; Kuiper JJ; Imhof SM; Lokhorst HM; Aniki R
Acta Ophthalmol; 2014 Feb; 92(1):82-7. PubMed ID: 23601505
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and risk factors associated with development of ocular GVHD defined by NIH consensus criteria.
Jacobs R; Tran U; Chen H; Kassim A; Engelhardt BG; Greer JP; Goodman SG; Clifton C; Lucid C; Vaughan LA; Savani BN; Jagasia M
Bone Marrow Transplant; 2012 Nov; 47(11):1470-3. PubMed ID: 22484321
[TBL] [Abstract][Full Text] [Related]
5. Onset of ocular graft-versus-host disease symptoms after allogeneic hematopoietic stem cell transplantation.
Shikari H; Amparo F; Saboo U; Dana R
Cornea; 2015 Mar; 34(3):243-7. PubMed ID: 25603230
[TBL] [Abstract][Full Text] [Related]
6. Ocular surface analysis in hematological patients before and after allogeneic hematopoietic stem cell transplantation: implication for daily clinical practice.
Giannaccare G; Bonifazi F; Sessa M; Dan E; Arpinati M; Fresina M; Bandini G; Cavo M; Versura P; Campos EC
Eye (Lond); 2017 Oct; 31(10):1417-1426. PubMed ID: 28524885
[TBL] [Abstract][Full Text] [Related]
7. Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India.
Khan R; Nair S; Seth T; Mishra P; Mahapatra M; Agarwal T; Tandon R; Vanathi M
Indian J Med Res; 2015 Nov; 142(5):543-8. PubMed ID: 26658588
[TBL] [Abstract][Full Text] [Related]
8. Ocular graft-versus-host disease after allogeneic stem cell transplantation.
Westeneng AC; Hettinga Y; Lokhorst H; Verdonck L; van Dorp S; Rothova A
Cornea; 2010 Jul; 29(7):758-63. PubMed ID: 20489577
[TBL] [Abstract][Full Text] [Related]
9. Correlation Between Tear Film Osmolarity and the Disease Score of the International Chronic Ocular Graft-Versus-Host-Disease Consensus Group in Hematopoietic Stem Cell Transplantation Patients.
Schargus M; Meyer-ter-Vehn T; Menrath J; Grigoleit GU; Geerling G
Cornea; 2015 Aug; 34(8):911-6. PubMed ID: 26075459
[TBL] [Abstract][Full Text] [Related]
10. Cannabidiol for the Prevention of Graft-versus-Host-Disease after Allogeneic Hematopoietic Cell Transplantation: Results of a Phase II Study.
Yeshurun M; Shpilberg O; Herscovici C; Shargian L; Dreyer J; Peck A; Israeli M; Levy-Assaraf M; Gruenewald T; Mechoulam R; Raanani P; Ram R
Biol Blood Marrow Transplant; 2015 Oct; 21(10):1770-5. PubMed ID: 26033282
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for the development of ocular graft-versus-host disease (GVHD) dry eye syndrome in patients with chronic GVHD.
Wang JC; Teichman JC; Mustafa M; O'Donnell H; Broady R; Yeung SN
Br J Ophthalmol; 2015 Nov; 99(11):1514-8. PubMed ID: 25947556
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of graft-versus-host disease occurring after alemtuzumab-containing allogeneic stem cell transplants: incidence, organ involvement, risk factors and survival.
Finazzi MC; Boschini C; Craddock C; Rambaldi A; Ward J; Malladi RK
Br J Haematol; 2020 Feb; 188(4):550-559. PubMed ID: 31713861
[TBL] [Abstract][Full Text] [Related]
13. Total Body Irradiation-Based Myeloablative Haploidentical Stem Cell Transplantation Is a Safe and Effective Alternative to Unrelated Donor Transplantation in Patients Without Matched Sibling Donors.
Solomon SR; Sizemore CA; Sanacore M; Zhang X; Brown S; Holland HK; Morris LE; Bashey A
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1299-307. PubMed ID: 25797174
[TBL] [Abstract][Full Text] [Related]
14. Validation of International Chronic Ocular Graft-Versus-Host Disease (GVHD) Group Diagnostic Criteria as a Chronic Ocular GVHD-Specific Metric.
Rapoport Y; Freeman T; Koyama T; Engelhardt BG; Jagasia M; Savani BN; Tran U; Kassim AA
Cornea; 2017 Feb; 36(2):258-263. PubMed ID: 28060078
[TBL] [Abstract][Full Text] [Related]
15. Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.
Arora M; Cutler CS; Jagasia MH; Pidala J; Chai X; Martin PJ; Flowers ME; Inamoto Y; Chen GL; Wood WA; Khera N; Palmer J; Duong H; Arai S; Mayer S; Pusic I; Lee SJ
Biol Blood Marrow Transplant; 2016 Mar; 22(3):449-55. PubMed ID: 26541363
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for chronic graft-versus-host disease after allogeneic stem cell transplantation in children.
Kondo M; Kojima S; Horibe K; Kato K; Matsuyama T
Bone Marrow Transplant; 2001 Apr; 27(7):727-30. PubMed ID: 11360113
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of dry eye syndrome after allogeneic hematopoietic stem cell transplantation.
Ivanir Y; Shimoni A; Ezra-Nimni O; Barequet IS
Cornea; 2013 May; 32(5):e97-101. PubMed ID: 23187163
[TBL] [Abstract][Full Text] [Related]
18. A Review of Ocular Graft-Versus-Host Disease.
Munir SZ; Aylward J
Optom Vis Sci; 2017 May; 94(5):545-555. PubMed ID: 28422804
[TBL] [Abstract][Full Text] [Related]
19. Ocular chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation in an Italian referral center.
Berchicci L; Rabiolo A; Marchese A; Iuliano L; Gigliotti C; Miserocchi E; Bandello F; Modorati G
Ocul Surf; 2018 Jul; 16(3):314-321. PubMed ID: 29625303
[TBL] [Abstract][Full Text] [Related]
20. Predictive models for ocular chronic graft-versus-host disease diagnosis and disease activity in transplant clinical practice.
Curtis LM; Datiles MB; Steinberg SM; Mitchell SA; Bishop RJ; Cowen EW; Mays J; McCarty JM; Kuzmina Z; Pirsl F; Fowler DH; Gress RE; Pavletic SZ
Haematologica; 2015 Sep; 100(9):1228-36. PubMed ID: 26088932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
